Clinical Trial Update: Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pembrolizumab plus ramucirumab in metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN